Disease Areas:
Smoking cessationDevice Types:
BreathCOThis paper describes the design of a double-blind, randomized trial that will evaluate the effect of isradipine versus placebo on the extinction of self-reported craving in adult cigarette smokers; planned recruitment is 102 subjects aged 18–65 years. Abstinence status will be verified using the Vitalograph BreathCO carbon monoxide monitor.